Canada-based hedge fund manager Anson Funds, primarily known for its wagers against stocks, is happy to play the waiting game on the US marijuana market after establishing a "very long" position on the sector, according to a report by Bloomberg.
Global macro specialist Brevan Howard has confirmed it is opening a new office in Abu Dhabi, having leased space at the Al Sarab Tower for more than one hundred people, and is relocating several senior executives from across the business to lead this expansion.
London-based hedge fund Oceanwood Capital Management has made around $150 million from a bet on bankrupt Norwegian newsprint manufacturer Norske Skog ASA, nearly five years after it bought the business out of bankruptcy, according to a report by Bloomberg.
Asia-focused hedge funds posted a 5.3% gain in January, their best monthly performance since 2016, as the share prices of Chinese companies rebounded strongly following the lifting of strict 'zero Covid' restrictions, according to a report by Reuters.
Hedge funds Scion Asset Management, the firm run by "Big Short" investor Michael Burry, Farallon Capital Management, and Coatue Management are among the big name firms who made large bets on Chinese companies in January, ahead of the country abandoning its 'zero Covid' restrictions, according to a report by Reuters.
Bridgwater Associates, the hedge fund firm founded by Ray Dalio, almost tripled the size of its bets on both GameStop and AMC during the final quarter of 2022, according to a report by Business Insider India.
Element Capital, one of the world’s biggest macro hedge funds, is responding to a recent string of poor returns, including a $1 billion loss during last month's stock market rally, by reducing its $12 billion asset base in a bid to improve performance, according to a report by the Financial Times.
Pershing Square Capital Management, the hedge fund firm founded by Bill Ackman, finished 2022 with a 9% loss despite raking in some $2.7 billion from winning interest rate bets over the course of the year, according to a report by Reuters.
Qube Research & Technologies, a hedge fund that was spun out of Credit Suisse Group in 2018, is planing to boost its multi-strategy investment business by allocating hundreds of millions of dollars to external money managers, according to a report by Bloomberg.
South Korean activist investor the Korea Corporate Governance Improvement Fund, is to sell its 6.92% stake in Osstem Implant Co to a consortium of private equity firms looking to gain control of the dental implant specialist, according to a report by the Korea Economic Daily.